CD109

From Wikipedia, the free encyclopedia
Jump to: navigation, search
CD109
Identifiers
Aliases CD109, CPAMD7, p180, r150, CD109 molecule
External IDs MGI: 2445221 HomoloGene: 25183 GeneCards: 135228
RNA expression pattern
PBB GE CD109 gnf1h04600 at tn.png

PBB GE CD109 gnf1h06370 at tn.png

PBB GE CD109 gnf1h07791 at tn.png
More reference expression data
Orthologs
Species Human Mouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001159587
NM_001159588
NM_133493

NM_153098

RefSeq (protein)

NP_001153059.1
NP_001153060.1
NP_598000.2

NP_694738.1

Location (UCSC) Chr 6: 73.7 – 73.83 Mb Chr 9: 78.62 – 78.72 Mb
PubMed search [1] [2]
Wikidata
View/Edit Human View/Edit Mouse

CD109 (Cluster of Differentiation 109) is a human gene.[1]

CD109 is a GPI-linked cell surface antigen expressed by CD34+ acute myeloid leukemia cell lines, T-cell lines, activated T lymphoblasts, endothelial cells, and activated platelets (Lin et al., 2002). In addition, the platelet-specific Gov antigen system, implicated in refractoriness to platelet transfusion, neonatal alloimmune thrombocytopenia, and posttransfusion purpura, is carried by CD109 (Kelton et al., 1990; Lin et al., 2002).[supplied by OMIM][1]

See also[edit]

References[edit]

Further reading[edit]

External links[edit]